Аннотация
This chapter addresses manufacturing, regulatory, and commercialization pathways for MSC–EV-based therapeutics. It discusses GMP-compliant production, process scalability, and comparability challenges. Regulatory frameworks from major agencies are analyzed, with emphasis on potency assays, quality control, and lifecycle management. The chapter also explores industrial translation and economic considerations for bringing EV-based products to market.